Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease.
Foot-and-mouth disease (FMD) is a highly contagious disease that occasionally causes outbreaks in Europe. There is a need for therapies that provide rapid protection against FMD in outbreak situations. We aim to provide such rapid protection by passive immunization with llama single-domain antibody fragments (VHHs). Twenty-four VHHs binding serotype O FMDV in vitro were isolated from immunized llamas by phage display and expressed in bakers yeast for further characterization. They recognized four functionally independent antigenic sites. Six strongly FMDV neutralizing VHHs bound to a peptide representing the GH-loop of viral protein 1 known to be involved in binding to the cellular receptor of FMDV. Clone M8, recognizing this antigenic site, and clone M23, recognizing another antigenic site, showed synergistic in vitro virus neutralization. Three FMDV specific VHHs were PEGylated in order to decrease their rapid blood clearance and thus enable in vivo guinea pig protection experiments. Passive immunization with individual VHHs showed no protection, but a mixture of M8 and M23 showed partial transient protection. The protection afforded by these VHHs was however low as compared to the complete protection afforded by convalescent guinea pig serum. In contrast, these VHHs showed far more efficient in vitro FMDV neutralization than convalescent guinea pig serum. This lack of correlation between in vitro neutralization and in vivo protection lends further credence to the notion that opsonophagocytosis of FMDV is important for protection in vivo.
Harmsen
M M
MM
Animal Sciences Group of Wageningen University and Research Centre, 8200 AB Lelystad, The Netherlands. michiel.harmsen@wur.nl
van Solt
C B
CB
Fijten
H P D
HP
van Keulen
L
L
Rosalia
R A
RA
Weerdmeester
K
K
Cornelissen
A H M
AH
De Bruin
M G M
MG
Eblé
P L
PL
Dekker
A
A
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000008:administration & dosage* / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics; D002161:Camelids, New World / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005536:Foot-and-Mouth Disease / Q000276:immunology / Q000517:prevention & control*; D029544:Foot-and-Mouth Disease Virus / Q000276:immunology*; D006168:Guinea Pigs; D007116:Immunization, Passive / Q000379:methods / Q000662:veterinary*; D007128:Immunoglobulin Fragments / Q000008:administration & dosage / Q000235:genetics; D007135:Immunoglobulin Variable Region / Q000276:immunology; D008297:Male; D008969:Molecular Sequence Data; D009500:Neutralization Tests / Q000662:veterinary; D010802:Phylogeny; D011994:Recombinant Proteins / Q000097:blood / Q000235:genetics; D012441:Saccharomyces cerevisiae / Q000235:genetics; D016415:Sequence Alignment
D000914:Antibodies, Viral; D007128:Immunoglobulin Fragments; D007135:Immunoglobulin Variable Region; D011994:Recombinant Proteins